Rapid Antigen Test for Novel Corona Virus
- UID
- MFG/IVD/2021/000053_3cb38ebdb82e1623e9d8ea90cec2ee12_e6959bffc93230d6ef2e0531361f278a
- Device class
- Class C
- Brand name
- nCOVID-19
- License holder
- Dia Sure Immunodiagnostic LLP
- Approving authority
- CDSCO -North Zone, Ghaziabad
- Product information
- DSI Covid-19 Ag Rapid Test is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in nasopharyngeal swab, using the rapid immuno- chromatographic method.
Rapid Antigen Test for Novel Corona Virus is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000053_3cb38ebdb82e1623e9d8ea90cec2ee12_e6959bffc93230d6ef2e0531361f278a. This device is marketed under the brand name nCOVID-19. The license holder is Dia Sure Immunodiagnostic LLP, and it is classified as Device Class Class C. The approving authority is CDSCO -North Zone, Ghaziabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.